Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition
about
C-Jun N-terminal kinase signalling pathway in response to cisplatinAnnexin A4 induces platinum resistance in a chloride-and calcium-dependent mannerSynergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis.High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyMicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer.Let-7a gene knockdown protects against cerebral ischemia/reperfusion injury.Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer.MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
Q26745463-53C01C2F-E5DB-4997-BDB4-E61D4ABB8044Q34365873-33ABE61D-CED1-4284-8959-D166260B3909Q35176405-4BE0D70B-E4E6-4DE5-8254-AD70794EB5F9Q35686424-E341E5B7-89DD-4A1C-8637-02C5537E5560Q36413197-FC309A66-2909-475A-8449-63936FF1BA2FQ36737486-F0267B23-B1FD-4EFB-B2FA-ADFED3B8AFA4Q36962940-4CC26671-ADA8-430F-95EF-31C92DCA1F0BQ38546133-D4347D17-E3AE-47C1-99A1-E67BE914FE23Q38810052-0E6337FB-276A-4857-957D-EB7FAF6E6692Q39817084-7AF16C0C-A3B2-4DDE-BE2D-FD3E8D4D409FQ46227416-884C6A51-CB87-4470-9E54-708EB2C890A3Q47193877-6B1E425D-4DAB-4088-82BB-1D6FFB5C9F23Q48846069-A6ED58B4-AFE7-46ED-98FE-4E49EFE8C002Q53577261-00D270B9-82AF-4BF2-BBA3-4DAAF15E215BQ53700829-541A5AA2-8A3B-4EF2-B909-0367D21A3C39Q57471242-FB15EB59-591E-4D46-9A74-0D189EBCFD07Q58694197-BBD92DC2-D62E-4FB0-91DF-641E0305FC83
P2860
Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@ast
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@en
Retaining MKP1 expression and ...... ce through miR-940 inhibition.
@nl
type
label
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@ast
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@en
Retaining MKP1 expression and ...... ce through miR-940 inhibition.
@nl
prefLabel
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@ast
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@en
Retaining MKP1 expression and ...... ce through miR-940 inhibition.
@nl
P2093
P2860
P356
P1433
P1476
Retaining MKP1 expression and ...... nce through miR-940 inhibition
@en
P2093
Mabel T Padilla
Qiong Wang
Shaoqing Shi
Weiyang He
P2860
P304
P356
10.18632/ONCOTARGET.1798
P407
P577
2014-03-01T00:00:00Z